ProteinQure leverages quantum molecular simulations and AI to accelerate drug discovery and development, using quantum-enhanced computational methods to model complex molecular interactions and protein dynamics that are challenging for classical computers, enabling more accurate predictions of drug efficacy and safety for pharmaceutical applications.
Moe Nadeem (Co-founder, CEO), Trent McConaghy (Co-founder)
Explore other quantum computing companies in similar categories or regions.